Invention Grant
- Patent Title: Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid
-
Application No.: US17396464Application Date: 2021-08-06
-
Publication No.: US11884696B2Publication Date: 2024-01-30
- Inventor: Paul Steven Watson , Bret Berner , John Gregory Reid , Jian Wang , James J. Doherty , Stephen Jay Kanes
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Kathryn D. Doyle; Jonathan P. O'Brien
- Main IPC: C07J43/00
- IPC: C07J43/00 ; C07D231/14 ; A61P25/22 ; A61P25/18 ; A61P25/24 ; A61P25/00 ; A61P25/08 ; A61P37/00
Abstract:
This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I),
and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.
and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.
Public/Granted literature
- US20220169674A1 A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID Public/Granted day:2022-06-02
Information query
